Question

Schedule Y

05 Mar 2024
Answer :
Word Count : 425

Schedule Y is a set of guidelines outlined by the Central Drugs Standard Control Organization (CDSCO) in India for the regulation and approval of clinical trials and new drug applications. It serves as a comprehensive framework to ensure the safety, efficacy, and quality of pharmaceutical products introduced in the Indian market. Here's a breakdown of key components and requirements within Schedule Y:

1. Clinical Trial Approval: Schedule Y mandates that ________ _______ _________ ___ ________ ____ _______ ______ _____ _______ _____ ______.
___ ____ ________ _________ _________ __________ _______ __________ ______ ____ __________ ________.
________ _____ ______ ____ _______ ________ _________ ___ ______.
_____ _____ ___ ____ ________ ___ ________ ____ _____ ________ _______ ______.
___ ______ ______ ________ _______ _______ _______ _________.
______ __________ _________ _______ ______ ________ _________ ______ ___ __________ _______ ____.
_________ ___ ____ ________ ___ ________ _______ ______.
____ _____ ________ ______ _______ _____ ___ ______ _______ ______ __________.
___ ___ ___ ___ ________ _________ _____.
____ ___ ________ ___ ___ ________ __________.
___ __________ ____ ______ _____ ______ _______ __________ _____.
______ ________ ____ _______ __________ ____.
____ _________ ________ _______ __________ _________ ______.
________ _________ ________ ______ _______ ______ _________ ____ ______.
_________ __________ ___ ________ ____ ______ __________ _________ _______ _______.
____ _____ _________ _____ _________ ______ ___ ________.
_________ ______ __________ _______ _________ ___ _________ ______ _________ ________ _____.
_______ _________ __________ ___ _____ ______ ___ _____.
________ _____ _____ ______ ________ ______ _________ _________ _________ ___.
_________ ___ ________ __________ ____ _________ ________ _______.
____ _________ _________ ____ _______.
____ _________ _________ ______ ________ _______ _______ __________ _________.
________ _____ ______ __________ _____ ___.
__________ ____ ______ _________ _____ ___ ___ _________ _______.
___ __________ ____ _______ ______ ________ ____ ___.
_________ _______ _________ ____ _________ ______ _______ ___.
__________ _____ __________ ______ __________ ____ ___ _________.
__________ ____ ________ ___ _____ ____ ______ ____ __________.
__________ ___ _________ _____ ________ _________ ____ __________ ______ _________.
________ ___ ____ _____ __________ _________ ___ _____.
_____ ________ _____ __________ _________.
______ _____ __________ _____ __________ __________ ________.
_____ _________ _______ __________ __________ ____ ___ ___.
_________ _______ ___ _________ ________ _______ _________ ___ __________.
___ ________ _______ ______ _____.
________ _________ _________ _______ _________.
_________ _______ ______ _________ ____.
______ ______ _________ ____ ___ ______ __________ _________ _______ _______ ______ ___.
_______ ____ ________ ___ ________ _________ ______ ___ ____ ____ _________.
__________ __________ ________ ____ _____ ________.
__________ _________ ___ ____ ____ _________ ____ ____ _____ ___.
________ ____ ______ ________ ___ ____ ____.
__________.
Get Full Answer on WhatsApp

IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★
Top
📞
Call Support Instant phone assistance Schedule Y
→
🟢
WhatsApp Chat Fast live messaging
→
Email Us Business enquiries & support
→